![Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS](https://www.pnas.org/content/117/1/292/F1.large.jpg)
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
![Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire | Immunology Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire | Immunology](https://www.frontiersin.org/files/Articles/408358/fimmu-09-02249-HTML/image_m/fimmu-09-02249-g002.jpg)
Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire | Immunology
![Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? | Immunology Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? | Immunology](https://www.frontiersin.org/files/MyHome%20Article%20Library/561146/561146_Thumb_400.jpg)
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? | Immunology
![Biomedicines | Free Full-Text | Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions | HTML Biomedicines | Free Full-Text | Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions | HTML](https://www.mdpi.com/biomedicines/biomedicines-08-00319/article_deploy/html/images/biomedicines-08-00319-g006-550.jpg)
Biomedicines | Free Full-Text | Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions | HTML
![Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice | PNAS Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice | PNAS](https://www.pnas.org/content/pnas/111/14/5153/F1.large.jpg)
Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice | PNAS
![SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain](https://minio.scielo.br/documentstore/1806-0870/bmKRgcYXXQnRYh8pxk4mj5Q/5bd873428955d5251700c948e7a67ec7a186cd92.jpg)
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
![Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire | Immunology Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire | Immunology](https://www.frontiersin.org/files/MyHome%20Article%20Library/408358/408358_Thumb_400.jpg)
Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire | Immunology
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
![The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332216323745-gr2.jpg)
The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect
![Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez](https://www.jahjournal.org/articles/2015/6/2/images/JApplHematol_2015_6_2_43_160196_u4.jpg)
Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez
![Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S151684841500170X-gr2.jpg)
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
![Manni Mohyuddin on Twitter: "So as a junior myeloma faculty, I see a lot of consults for MGUS. Heres a tweetorial on how to interpret light chain values in the setting of Manni Mohyuddin on Twitter: "So as a junior myeloma faculty, I see a lot of consults for MGUS. Heres a tweetorial on how to interpret light chain values in the setting of](https://pbs.twimg.com/media/FA9zmfAUYAMAguw.png)